X-W Wang
Overview
Explore the profile of X-W Wang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
530
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang X, Chen X, Zhao Q, Huang X, Wang X, Long X
Int J Oral Maxillofac Surg
. 2022 Feb;
51(8):1050-1054.
PMID: 35210126
Lower lip hypoesthesia is the most common complication following osseous genioplasty. Concentrated growth factor (CGF) has recently been shown to improve neural regeneration. The aim of this study was to...
2.
Wei H, He W, Chen K, Wang X, Yi C
Eur Rev Med Pharmacol Sci
. 2021 Apr;
25(8):3147.
PMID: 33928594
Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, "MiR-101 affects proliferation and...
3.
Tan T, Xu X, Lu X, Wang X
Eur Rev Med Pharmacol Sci
. 2020 Feb;
24(2):712-720.
PMID: 32016973
Objective: To uncover the biological role of microRNA-200a-3p (miRNA-200a-3p) in the progression of non-small cell lung cancer (NSCLC) and the underlying mechanism. Patients And Methods: The expression levels of miRNA-200a-3p...
4.
Wei H, He W, Chen K, Wang X, Yi C
Eur Rev Med Pharmacol Sci
. 2019 Jul;
23(13):5640-5647.
PMID: 31298355
Objective: JAK2 expression and dysfunction play a role in tumor pathogenesis. Bioinformatics analysis revealed a targeted binding site between miR-101 and the 3'-UTR of JAK2 mRNA. This study investigated the...
5.
Wang X, Zhang W
Eur Rev Med Pharmacol Sci
. 2019 May;
23(8):3261-3269.
PMID: 31081078
Objective: Increasing evidence has indicated that long non-coding RNA cancer susceptibility candidate 2 (CASC2) is aberrantly expressed and acts as a key regulator in various types of cancer. However, few...
6.
Jiang J, Lv Q, Yi Y, Liao J, Wang X, Zhang W
Eur Rev Med Pharmacol Sci
. 2018 Oct;
22(19):6260-6267.
PMID: 30338796
Objective: We investigate whether microRNA-200a could regulate proliferation and invasion of ovarian cancer cells, thereby participating in the occurrence and development of ovarian cancer. We also explore the specific mechanism...
7.
Wei H, Wang X, Chen K, Ling S, Yi C
Eur Rev Med Pharmacol Sci
. 2018 Oct;
22(19):6280-6287.
PMID: 30338793
Objective: Cervical cancer is frequent in females. Epidermal growth factor receptor has a prominent expression in certain malignant tumors. This study aims to observe the expressional profile of epidermal growth...
8.
Lin C, Duan K, Wang X, Zhang Z
Eur Rev Med Pharmacol Sci
. 2018 Jun;
22(12):3663-3668.
PMID: 29949138
Objective: To investigate the role and potential mechanism of human serum albumin (hsa)-micro ribonucleic acid (miR)-382-5p in epidural fibrosis formation after laminectomy. Materials And Methods: Cells were transfected with miR-382-5p...
9.
Lin C, Duan K, Wang X, Zhang Z
Eur Rev Med Pharmacol Sci
. 2018 Jun;
22(12):3649-3655.
PMID: 29949136
Objective: To explore the role of microRNA-409 in spinal cord injury (SCI) recovery and its underlying mechanism. Materials And Methods: The mouse SCI model was first established, and the difference...
10.
Wang R, Wang X, Shibuya K, Li R
Br J Dermatol
. 2018 Jun;
178(6):e394.
PMID: 29897112
No abstract available.